Open an account

Medtronic

MDT · NYSE

$94.63+$1.86 (+2.00%)TodayMarket closed ·
Prev close $92.77

About MDT

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.

Employees
95,000
Headquarters
GALWAY, Dublin
Listed
Nov 21, 1977
Sector
Health Care
Industry
Health Care Equipment & Supplies
Website
medtronic.com

MDT key statistics

Market cap
121.05B
Price-earnings ratio
22.79
Dividend yield
3.03%
Average volume
33.89M
Volume
14.85M
Open price
$93.42
High today
$94.92
Low today
$93.42
52 Week high
$106.33
52 Week low
$73.31

Medtronic (MDT) at a glance

Medtronic (MDT) last traded at $94.63, with a market cap of 121.05B, a price-to-earnings ratio of 22.79 and a dividend yield of 3.03%.

Today the stock has traded between $93.42 and $94.92. The current price is 1.3% above the day's low and 0.3% below its high.

Volume so far is 14.85M shares, below the average of 33.89M shares a day.

Over the past year Medtronic has ranged from $73.31 to $106.33, and now sits 65% of the way up that range.

Medtronic met or beat analyst EPS estimates in 5 of the last 8 quarters. In Q2 FY26 it reported $1.45 per share against an estimate of $1.40.

The average analyst price target is $107.19, 13.3% above the current price, from 25 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

68%of 25 analyst ratings say Buy
  • Buy68.0%
  • Hold32.0%
  • Sell0.0%
Price target · 28 analystsAvg $107.19
Low
$85.85
Now
$94.63
High
$127.05

MDT earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 5 of the last 8 quarters, by 2.3% on average.

  1. Q1 FY25: reported $1.23 per share against an estimate of $1.21
  2. Q2 FY25: reported $1.26 per share against an estimate of $1.26
  3. Q3 FY25: reported $1.39 per share against an estimate of $1.37
  4. Q4 FY25: reported $1.62 per share against an estimate of $1.59
  5. Q1 FY26: reported $1.55 per share against an estimate of $1.56
  6. Q4 FY26: reported $1.55 per share against an estimate of $1.56
  7. Q1 FY27: reported $1.45 per share against an estimate of $1.40
  8. Q2 FY26: reported $1.45 per share against an estimate of $1.40

MDT news

  • Press releasePRNewswire

    Medtronic Named to TIME Best Inventions of 2026 List for Stealth AXiS™ surgical system and Corsano™* multi-parameter wearable

  • Press releasePRNewswire

    Medtronic Completes Separation of MiniMed Group, Inc.

  • Press releasePRNewswire

    MiniMed Completes Separation from Medtronic

  • Press releasePRNewswire

    Medtronic Announces Final Results of MiniMed Group, Inc. Exchange Offer

  • Erica Kollmann

    Top 10 Powder Keg Stocks Where Short Sellers Are Sitting on a Fuse

  • Press releasePRNewswire

    Medtronic Announces Preliminary Results of MiniMed Group, Inc. Exchange Offer

  • Avi Kapoor

    Jim Cramer Doesn’t Like This Health Care Stock, Sees No Reason To Buy Rambus

  • Avi Kapoor

    Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields

Similar companies

Companies in the same industry as Medtronic

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.